Shinva Medical Instrument released its 2026 interim report. Total operating revenue was 5.161 billion yuan, up 7.73% year-on-year, but net profit attributable to the parent company was 285 million yuan, down 26.04% year-on-year. Net cash inflow from operating activities was 265 million yuan, down 26.04% year-on-year. The company's asset-liability ratio was 45.21%, gross margin was 24.93%, return on equity was 3.63%, and diluted earnings per share was 0.47 yuan, down 26.56% year-on-year. Total asset turnover was 0.35 times, up 11.76% year-on-year, and inventory turnover was 1.40 times, up 25.77% year-on-year, achieving growth for two consecutive years. The company had 42,800 shareholders, and the top ten shareholders held 40.04% of total share capital.
Shinva Medical Instrument Co LtdNet profit down 26.04% year-on-year despite revenue growth.
